Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C9H7N5O3 |
| Molecular Weight | 233.1836 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC=C(\C=C\C2=CC=C(O2)[N+]([O-])=O)N=N1
InChI
InChIKey=RWOLIGKRDWLZSV-OWOJBTEDSA-N
InChI=1S/C9H7N5O3/c10-9-11-5-6(12-13-9)1-2-7-3-4-8(17-7)14(15)16/h1-5H,(H2,10,11,13)/b2-1+
| Molecular Formula | C9H7N5O3 |
| Molecular Weight | 233.1836 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5312990
The treatment with FURALAZINE (FL) was tested on 33 adults and 15 children who revealed typical cholera symptoms on admission. The intravenous fluid requirements of patients receiving FL were very similar to those of patients receiving CP.
Route of Administration:
Intravenous
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:23:20 GMT 2025
by
admin
on
Mon Mar 31 18:23:20 GMT 2025
|
| Record UNII |
2133JVQ6VE
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C254
Created by
admin on Mon Mar 31 18:23:20 GMT 2025 , Edited by admin on Mon Mar 31 18:23:20 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
6436102
Created by
admin on Mon Mar 31 18:23:20 GMT 2025 , Edited by admin on Mon Mar 31 18:23:20 GMT 2025
|
PRIMARY | |||
|
2133JVQ6VE
Created by
admin on Mon Mar 31 18:23:20 GMT 2025 , Edited by admin on Mon Mar 31 18:23:20 GMT 2025
|
PRIMARY | |||
|
1415
Created by
admin on Mon Mar 31 18:23:20 GMT 2025 , Edited by admin on Mon Mar 31 18:23:20 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106765
Created by
admin on Mon Mar 31 18:23:20 GMT 2025 , Edited by admin on Mon Mar 31 18:23:20 GMT 2025
|
PRIMARY | |||
|
SUB07830MIG
Created by
admin on Mon Mar 31 18:23:20 GMT 2025 , Edited by admin on Mon Mar 31 18:23:20 GMT 2025
|
PRIMARY | |||
|
70
Created by
admin on Mon Mar 31 18:23:20 GMT 2025 , Edited by admin on Mon Mar 31 18:23:20 GMT 2025
|
PRIMARY | |||
|
C007794
Created by
admin on Mon Mar 31 18:23:20 GMT 2025 , Edited by admin on Mon Mar 31 18:23:20 GMT 2025
|
PRIMARY | |||
|
C65780
Created by
admin on Mon Mar 31 18:23:20 GMT 2025 , Edited by admin on Mon Mar 31 18:23:20 GMT 2025
|
PRIMARY | |||
|
100000080694
Created by
admin on Mon Mar 31 18:23:20 GMT 2025 , Edited by admin on Mon Mar 31 18:23:20 GMT 2025
|
PRIMARY | |||
|
DTXSID30862193
Created by
admin on Mon Mar 31 18:23:20 GMT 2025 , Edited by admin on Mon Mar 31 18:23:20 GMT 2025
|
PRIMARY | |||
|
556-12-7
Created by
admin on Mon Mar 31 18:23:20 GMT 2025 , Edited by admin on Mon Mar 31 18:23:20 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |